Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2004 Dec;27(12):2800-5.
doi: 10.2337/diacare.27.12.2800.

Clinical outcomes and adherence to medications measured by claims data in patients with diabetes

Manel Pladevall  1 , L Keoki Williams, Lisa Ann Potts, George Divine, Hugo Xi, Jennifer Elston Lafata
Affiliations

Clinical outcomes and adherence to medications measured by claims data in patients with diabetes

Manel Pladevall et al. Diabetes Care. 2004 Dec.

Abstract

Objective: Although poor medication adherence may contribute to inadequate diabetes control, ways to feasibly measure adherence in routine clinical practice have yet to be established. The present study was conducted to determine whether pharmacy claims-based measures of medication adherence are associated with clinical outcomes in patients with diabetes.

Research design and methods: The study setting was a large, integrated delivery and financial system serving the residents of southeastern Michigan. The study population consisted of 677 randomly selected patients aged > or =18 years with a diagnosis of diabetes, hypercholesterolemia, and hypertension and who filled at least one prescription for either an antidiabetic, lipid-lowering, or antihypertensive drug in each of the 3 study years (1999-2001). The main outcome measures were HbA1c, LDL cholesterol levels, and blood pressure.

Results: Nonadherent patients had both statistically and clinically worse outcomes than adherent patients. Even after adjusting for demographic and clinical characteristics, nonadherence was significantly associated with HbA1c and LDL cholesterol levels. A 10% increase in nonadherence to metformin and statins was associated with an increase of 0.14% in HbA1c and an increase of 4.9 mg/dl in LDL cholesterol levels. Nonadherence to ACE inhibitors was not significantly associated with blood pressure.

Conclusions: Claims-based measures of medication adherence are associated with clinical outcomes in patients with diabetes and may therefore prove to be useful in clinical practice. More research is needed on methods to introduce claims-based adherence measurements into routine clinical practice and how to use these measurements to effectively improve adherence and health outcomes in chronic care management.

PubMed Disclaimer

References

    1. Dunbar-Jacob J, Mortimer-Stephens MK. Treatment adherence in chronic disease. J Clin Epidemiol. 2001;54:S57–S60. - PubMed
    1. Haynes RB, McDonald H, Garg AX, Mon-tague P. Interventions for helping patients to follow prescriptions for medications (Review) Cochrane Database Syst Rev. 2002:CD000011. - PubMed
    1. Sabaté E. Adherence to long-term therapies: evidence for action. Geneva, World Health Org. [article online]. Accessed 5 March 2004. Available from http://www.who.int/chronic_conditions/adherencereport/en/
    1. Roter DL, Hall JA, Merisca R, Nordstrom B, Cretin D, Svarstad B. Effectiveness of interventions to improve patient compliance: a meta-analysis. Med Care. 1998;36:1138–1161. - PubMed
    1. DiMatteo MRP. Variations in patients’ adherence to medical recommendations: a quantitative review of 50 years of research. Med Care. 2004;42:200–209. - PubMed

Publication types